ORMP
Oramed Pharmaceuticals Inc
NASDAQ: ORMP · HEALTHCARE · BIOTECHNOLOGY
$3.88
+1.04% today
Updated 2026-04-30
Market cap
$163.00M
P/E ratio
2.69
P/S ratio
81.50x
EPS (TTM)
$1.50
Dividend yield
—
52W range
$2 – $4
Volume
0.1M
Oramed Pharmaceuticals Inc (ORMP) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | $197412.00 | $184254.00 | — | — | — | $641000.00 | $2.46M | $2.45M | $2.70M | $2.71M | $2.70M | $2.70M | $1.34M | $0.00 | $2.00M |
| Revenue growth (YoY) | — | — | — | — | — | — | -6.7% | -100.0% | — | — | — | +283.2% | -0.3% | +10.4% | +0.3% | -0.3% | +0.0% | -50.4% | -100.0% | — |
| Cost of revenue | — | — | — | — | — | — | — | — | — | — | $490000.00 | $187000.00 | $86000.00 | $90000.00 | $90000.00 | — | — | — | $193000.00 | $1.99M |
| Gross profit | — | — | — | — | — | $197412.00 | $184254.00 | — | — | — | $151000.00 | $2.27M | $2.36M | $2.61M | $2.62M | $2.70M | $2.70M | $1.34M | $-193000.00 | $13000.00 |
| Gross margin | — | — | — | — | — | 100.0% | 100.0% | — | — | — | 23.6% | 92.4% | 96.5% | 96.7% | 96.7% | 100.0% | 100.0% | 100.0% | — | 0.7% |
| R&D | $197748.00 | $2.21M | $1.18M | $1.52M | $1.46M | $1.16M | $1.68M | $2.27M | $3.28M | $4.78M | $7.71M | $10.28M | $11.98M | $13.52M | $10.23M | $20.99M | $27.64M | $8.97M | $6.32M | $6.38M |
| SG&A | $215135.00 | $918000.00 | $1.50M | $1.26M | $1.51M | $1.28M | $1.20M | $2.03M | $2.63M | $2.60M | $2.45M | $2.76M | $4.08M | $3.72M | $4.23M | $5.94M | $13.81M | $8.43M | $6.46M | $8.72M |
| Operating income | $-412883.00 | $-3.13M | $-2.68M | $-2.78M | $-2.97M | $-2.44M | $2.88M | $-4.30M | $-5.91M | $-7.38M | $-10.01M | $-10.77M | $-13.53M | $-14.63M | $-11.76M | $-24.22M | $-40.60M | $-15.77M | $-12.78M | $-15.09M |
| Operating margin | — | — | — | — | — | -1233.6% | 1565.2% | — | — | — | -1561.6% | -438.6% | -552.3% | -541.3% | -433.8% | -896.2% | -1502.0% | -1176.8% | — | -754.4% |
| EBITDA | $-412883.00 | $-3.02M | $-2.66M | $-2.72M | $-2.92M | $-2.37M | $-2.86M | $-4.13M | $-5.67M | $-7.38M | $-9.99M | $-10.76M | $-13.49M | $-14.17M | $-11.31M | $-25.04M | $-36.98M | $7.32M | $-14.87M | $-15.09M |
| EBITDA margin | — | — | — | — | — | -1202.4% | -1550.1% | — | — | — | -1558.3% | -437.9% | -550.9% | -524.3% | -417.4% | -926.3% | -1368.0% | 546.3% | — | -754.4% |
| EBIT | $-411190.00 | $-3.13M | $-2.68M | $-2.75M | $-2.95M | $-2.40M | $-2.87M | $-4.14M | $-5.68M | $-7.38M | $-9.99M | $-10.76M | $-13.50M | $-14.18M | $-11.32M | $-25.12M | $-40.60M | $7.13M | $-15.07M | — |
| Interest expense | $3684.00 | $3.24M | $10281.00 | $17555.00 | $14544.00 | $18780.00 | $199123.00 | $313446.00 | $11000.00 | — | $11000.00 | $6000.00 | $6000.00 | $126000.00 | — | $6000.00 | $2.93M | $3.58M | $853000.00 | $0.00 |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-414576.00 | $-3.24M | $-2.77M | $-2.76M | $-2.98M | $-1.56M | $-3.34M | $-4.23M | $-5.70M | $-7.23M | $-10.96M | $-10.48M | $-12.73M | $-14.36M | $-11.51M | $-22.24M | $-37.76M | $5.53M | $-19.10M | $75.32M |
| Net income growth (YoY) | — | -680.6% | +14.4% | +0.3% | -7.9% | +47.6% | -114.2% | -26.5% | -34.6% | -27.0% | -51.6% | +4.4% | -21.4% | -12.8% | +19.8% | -93.2% | -69.8% | +114.6% | -445.8% | +494.3% |
| Profit margin | — | — | — | — | — | -790.9% | -1815.1% | — | — | — | -1710.5% | -426.7% | -519.7% | -531.1% | -424.8% | -822.7% | -1397.1% | 412.3% | — | 3766.2% |